Effectiveness and safety of the combination drug "Femo-Klim" evaluated in patients with former cancer and moderate menopausal disorders

Q3 Medicine

Obstetrics, Gynecology and Reproduction Pub Date : 2024-03-06 DOI:10.17749/2313-7347/ob.gyn.rep.2024.484

О. Vinogradova, О. Biryuchkova, S. Mikheeva

引用次数: 0

Abstract

Aim: to assess effectiveness and safety of a combination phytoestrogen-based product “Femo-Klim” in treatment of moderate climacteric disorders in gynecological cancer patients.

查看原文本刊更多论文

评估联合药物 "Femo-Klim "在前癌症和中度更年期失调患者中的有效性和安全性

目的：评估以植物雌激素为基础的复方产品 "Femo-Klim "在治疗妇科癌症患者中度气候失调方面的有效性和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obstetrics, Gynecology and Reproduction Medicine-Embryology

CiteScore

1.00

自引率

0.00%

发文量

审稿时长

12 weeks